
New Drug to Treat Multiple Sclerosis Awaits FDA Approval
Federal regulators will decide in March whether to put MS drug on the market that has performed well in clinical trials.
The post New Drug to Treat Multiple Sclerosis Awaits FDA Approval appeared first on
Healthline News.